Mitsubishi Tanabe Pharma Corporation (TYO: 4508) has been granted the marketing rights to HGF plasmid for peripheral arterial diseases
, including CLI, in Japan and the US.
Pipeline Products for Peripheral Arterial Disease
(PAD)/ Peripheral Vascular Disease (PVD) - Overview 11
The key concept of vulnerable plaque, and its ability to reshape how we view the patient with arterial disease
, will be scrutinised from the perspective of the phytotherapist.
C-reactive protein predicts future arterial and cardiovascular events in patients with symptomatic peripheral arterial disease
17) Gregg EW et al studied the prevalence of peripheral arterial disease
in patients with or without diabetes over the age of 40 years using ankle brachial index.
A 47 year-old man known with untreated hypercholesterolemia, hypertension and smoking addiction is difficultly diagnosed with occlusive peripheral arterial disease
stage IV, eight months after the symptoms arose, symptoms consisting of intermittent claudication with a walking perimeter about 150 meters.
LOT 5: Supply monoplane angiography equipment with floor fixing - device used for the pathology of coronary, cerebrovascular and peripheral arterial disease
with FFR and OCT software + maximum including space planning, installation, commissioning and personnel training: 2 pcs.
Peripheral Arterial Disease
(PAD) is a common circulation problem in which the arteries of the legs become clogged or narrowed by the buildup of plaque, increasing a person's risk of heart attack, stroke and limb amputation.
People who develop Peripheral Arterial Disease
often experience calf pain because the disease causes the arteries to thicken leading to decreased levels of oxygen to muscles in the leg.
The lack of symptomalogy in people with obvious occlusive arterial disease
can be explained by the observation that they adapt to their physiological and anatomical limitations.
Studies concerning the prevalence of peripheral arterial disease
rely mainly on the Edinburgh questionnaire, which is used to screen for intermittent claudication, and on the ankle/brachial pressure index, used to detect asymptomatic disease.
Peripheral arterial disease
(PAD) is a disease of the arteries beyond the heart.
Objective: To determine the co-incidence of coronary artery disease (CAD) in patients investigated for peripheral arterial disease
(PAD), and to establish the relationship between the risk factors in the two groups of patients.
Background: Peripheral arterial disease
is common in diabetics.
based Decision Resources, a research and advisory firm for pharmaceutical and healthcare issues, believes that the uptake of novel stem cell therapies expected to launch in 2016 will drive the drug market for peripheral arterial disease